| Literature DB >> 30419724 |
In Teak Woo1, Jun Seok Park1, Gyu-Seog Choi1, Soo Yeun Park1, Hye Jin Kim1, In Kyu Park1.
Abstract
PURPOSE: Redo surgery in patients with a persistent anastomotic failure (PAF) is a rare procedure, and data about this procedure are lacking. This study aimed to evaluate the surgical outcomes of redo surgery in such patients.Entities:
Keywords: Laparoscopy; Persistent anastomotic failure; Rectal cancer; Redo surgery
Year: 2018 PMID: 30419724 PMCID: PMC6238803 DOI: 10.3393/ac.2018.05.04
Source DB: PubMed Journal: Ann Coloproctol ISSN: 2287-9714
Fig. 1.Flowchart to obtain the results of a curative resection for rectal cancer patients. F/U, follow-up; RVF, recto vaginal fistula.
Characteristics of the patients who underwent redo surgery (n = 32)
| Characteristic | Value |
|---|---|
| Age (yr) | 60.6 ± 10.6 |
| Sex, male : female (%) | 19 (59.3) : 13 (40.7) |
| Body mass index (kg/m2) | 23.4 ± 3.1 |
| Tumor distance from AV (cm) | 5.5 (1–12) |
| Anastomosis level of AV (cm) | 3 (0–8) |
| ASA PS classification (%) | |
| I | 15 (46.8) |
| II | 16 (50.0) |
| III | 1 (3.1) |
| Diabetes mellitus | 2 (6.3) |
| Interval from primary surgery to redo surgery (mo) | 7.3 (6–126.7) |
| IMA tie (%) | |
| High tie | 31 (96.9) |
| Low tie | 1 (3.1) |
| Preoperative CCRT | 17 (53.1) |
| Type of primary anastomosis | |
| Stapled colorectal anastomosis | 17 (53.1) |
| Stapled coloanal anastomosis | 4 (12.5) |
| Hand-sewn coloanal anastomosis | 11 (34.3) |
Values are presented as mean ± standard deviation, number (%), or median (interquartile range).
AV, anal verge; ASA PS, American Society of Anesthesiologists physical status; IMA, inferior mesenteric artery; CCRT, combined chemotherapy and radiation therapy.
Pre- and postoperative details of the patients who underwent redo surgery (n = 32)
| Variable | Value |
|---|---|
| Redo surgery | |
| Laparoscopic approach : open approach | 19 (59.3) : 13 (40.7) |
| Ileostomy at redo surgery | 22 (68.7) |
| Operation time (min) | 223.4 ± 81 |
| Blood loss (mL) | 81.7 ± 380 |
| Postoperative hospital stay (day) | 14 (6–195) |
| Complication[ | 13 (40.6) |
| Clavien-Dindo classification I/II | 8 (25.0) |
| Small bowel obstruction | 3 |
| Wound complication | 3 |
| Voiding difficulty/UTI | 2 |
| Clavien-Dindo classification III | 5 (15.6) |
| Leakage | 4 |
| Presacral abscess | 1 |
| Long-term success | |
| Success without reintervention | 23 (71.8) |
| Success with reintervention | 2 (6.2) |
| Failure with persisting stoma | 7 (21.8) |
| Mortality[ | 0 (0) |
Values are presented as number (%), mean ± standard deviation, or median (interquartile range).
UTI, urinary tract infection.
Complication & mortality are postoperative within 90 days.
Details for the 7 patients who failed redo surgery
| Patients | Sex | Age (yr) | BMI (kg/m2) | ASA | Tumor height (cm) | Pre- CCRT | cT stage | Reason for redo | Procedure before redo surgery | Tool | OP time (min) | Hospital stay (day) | Morbidity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 68 | 16 | II | 5 | Yes | III | Sinus | Drain | Lapa | 120 | 7 | Sinus |
| 2 | M | 79 | 18 | II | 7 | No | I | Sinus | Repair | Open | 380 | 56 | Sinus |
| 3 | M | 43 | 23 | I | 3 | Yes | IV | Steno | No | Lapa | 240 | 6 | Sinus |
| 4 | M | 55 | 23 | III | 3 | Yes | II | Steno | Redo surgery | Open | 120 | 122 | Sinus |
| 5 | F | 74 | 24 | II | 5 | No | III | Fistula | No | Lapa | 300 | 10 | Rectovaginal fistula |
| 6 | M | 52 | 25 | II | 7 | Yes | III | Sinus | No | Open | 250 | 30 | Pelvic area tumor recurrence |
| 7 | F | 83 | 23 | I | 5 | Yes | III | Fistula | Repair | Lapa | 180 | 17 | Incontinence |
BMI, body mass index; AV, anal verge; ASA, American Society of Anesthesiologists physical status classification; IMA, inferior mesenteric artery; CCRT, combined chemotherapy and radiation therapy; cT stage, clinical T stage; OP, operation; Lapa, laparoscopy.
Results of univariate and multivariate analyses using Cox proportional-hazard regression for risk variables of persistent anastomotic failure requiring a redo anastomosis
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Sex | ||||
| Female | 1 | - | 0.875 (0.416–1.840) | 0.725 |
| Male | 1.238 | 0.569 | 1 | - |
| Age (yr) | ||||
| <70 | 1 | - | 1.620 (0.663–3.960) | 0.290 |
| ≥70 | 0.529 | 0.155 | 1 | - |
| Body mass index (kg/m2) | ||||
| <27.5 | 1 | - | - | |
| ≥27.5 | 0.891 | 0.850 | 0.841 | |
| Tumor height (cm) | ||||
| <5 | 1 | - | 2.444 (1.033–5.783) | 0.042 |
| ≥5 | 0.622 | 0.227 | 1 | - |
| Surgical approach | ||||
| Low tie | 1 | - | 0.448 (0.059–3.419) | 0.439 |
| High tie | 2.685 | 0.313 | 1 | - |
| Preoperative CCRT | ||||
| No | 1 | - | 0.515 (0.192–1.382) | 0.188 |
| Yes | 2.121 | 0.145 | 1 | - |
| Anastomosis fashion | ||||
| Hand-sewn | 1 | - | 0.503 (0.218–1.162) | 0.108 |
| Stapled | 1.159 | 0.693 | 1 | - |
| Diabetes mellitus | ||||
| No | 1 | - | 0.631 (0.147–2.710) | 0.536 |
| Yes | 1.485 | 0.590 | 1 | - |
| Clinical T-stage | ||||
| T1–2 | 1 | - | 0.874 (0.416–1.836) | 0.722 |
| T3–4 | 1.092 | 0.814 | 1 | - |
CCRT, combined chemotherapy and radiation therapy; HR, hazard ratio; CI, confidence interval.